{"id":47202,"date":"2022-08-11T17:02:15","date_gmt":"2022-08-11T15:02:15","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\/"},"modified":"2022-08-11T17:02:15","modified_gmt":"2022-08-11T15:02:15","slug":"breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\/","title":{"rendered":"Breast Cancer Patients Now Have New Radiation Treatment Option that Visualizes the Heart and Addresses Co-Morbidities"},"content":{"rendered":"
\n

\nBrainlab Deep Inspiration Breath Hold with ExacTrac Dynamic\u00ae<\/sup> delivers new approach to solve challenges for wider cancer populations<\/i><\/b>\n<\/p>\n

CHICAGO–(BUSINESS WIRE)–#breastcancer<\/a>–Brainlab announced today the first group of breast cancer patients treated in United States with the ExacTrac Dynamic\u00ae<\/sup><\/a> Deep Inspiration Breath Hold<\/a> (DIBH) module. Highlands Oncology<\/a> is the first to treat and has already treated 19 patients in the first two weeks. By combining highly accurate surface guided technology with triggered X-ray imaging, Highlands Oncology clinicians have been able to address challenges that often necessitated large treatment margins, due to the lack of available technology and integration.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nBreast cancer is the most prevalent cancer for women in the United States and second most deadly cancer for females according to the US government and breast cancer advocacy groups. While strides have been made in numerous therapies and survival has continued to improve, one key area has remained a challenge for doctors treating breast cancer: reducing late cardiac toxicity<\/a> in their patients. In the ongoing pursuit of curative radiation treatment, clinicians find that they may undesirably irradiate the heart while attempting to eradicate breast cancer for left-sided cancer patients, as unmanaged breathing may bring the vital organ into the radiation targeting field. ExacTrac Dynamic\u00ae<\/sup> and its novel tracking technology actively monitors breathing with correlation to internal anatomy checks. New research<\/a> out of Brussels demonstrates that application of this technology helps reduce cardiac toxicity and the possibility of lung cancer for patients in certain risk groups including those with high blood pressure, high cholesterol and obesity, but also critically, for those with persistent smoking habits.\n<\/p>\n

\nUntil now, patients receiving breast cancer radiation treatments have been typically treated using large treatment margins and without the benefit of internal anatomical verification during treatment. By incorporating \u2018on-the-fly\u2019 X-Ray confirmation, Brainlab technology streamlines the process and delivers confidence that the heart is outside of the treatment beam. This solution delivers correlation between internal and external anatomy in one shot, revealing any misalignment that may otherwise remain undetected.\n<\/p>\n

\n\u201cThe clinical community has been waiting for a solution like this,\u201d said Hershey H. Garner, JD, MD, Chief of Radiation Oncology at Highlands Oncology. \u201cFor physicians, we often have the dilemma of shielding healthy tissue and organs at the expense of more aggressive cancer destruction. With ExacTrac Dynamic\u00ae<\/sup> and DIBH, we can now mitigate the risk to the heart with minimal trade off. We can now track a surrogate and image internal anatomy\u2014since Brainlab technology can do both simultaneously. We have trusted Brainlab for our most precise cranial setups and our team was impressed how easy it was to implement DIBH ‘out of the box’ technology for our breast cancer patients.\u201d\n<\/p>\n

\n\u201cWith this new technology, we knew the potential for increased clinician and patient interest would be high,\u201d said Sean Clark, President, Brainlab Inc. \u201cOur customers are very excited about adding this technology to their armamentarium of cancer-fighting technology. Helping wider patient populations with co-morbidities achieve better cancer outcomes aligns perfectly with our mission to increase access to and consistency of treatment.\u201d\n<\/p>\n

\nAbout Brainlab<\/b>\n<\/p>\n

\nBrainlab is a digital medical technology pioneer founded in 1989 and headquartered in Munich. The company employs more than 2000 people in 25 locations around the globe. Brainlab serves physicians, medical professionals and their patients in over 6000 hospitals in 121 countries.\n<\/p>\n

\nBrainlab creates software-driven medical solutions that digitize, automate and optimize clinical workflows for neurosurgery, spine, trauma, craniomaxillofacial (CMF), general and vascular surgery as well as radiotherapy and radiosurgery. Core products center around surgical navigation, radiotherapy, digital operating room integration, and information and knowledge exchange. The Brainlab open framework operating system will allow third parties to develop medical applications to further advance the field of spatial computing and mixed reality.\n<\/p>\n

\nBrainlab is dedicated to creating an impact in healthcare. The company connects opportunities from emerging digital technologies to transform healthcare at scale and help improve the lives of patients worldwide. For more information, please visit Brainlab<\/a> and follow on LinkedIn<\/a>, Twitter<\/a>, Facebook<\/a> and Instagram<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nDebbra Verard
\n
Director, Marketing and Communications
\n
+1 (708) 409-1343
\n
presse@brainlab.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Brainlab Deep Inspiration Breath Hold with ExacTrac Dynamic\u00ae delivers new approach to solve challenges for wider cancer populations CHICAGO–(BUSINESS WIRE)–#breastcancer–Brainlab announced today the first group of breast cancer patients treated in United States with the ExacTrac Dynamic\u00ae Deep Inspiration Breath Hold (DIBH) module. Highlands Oncology is the first to treat and has already treated 19 … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47202","6":"format-standard","7":"category-industry"},"yoast_head":"\nBreast Cancer Patients Now Have New Radiation Treatment Option that Visualizes the Heart and Addresses Co-Morbidities - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Breast Cancer Patients Now Have New Radiation Treatment Option that Visualizes the Heart and Addresses Co-Morbidities - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Brainlab Deep Inspiration Breath Hold with ExacTrac Dynamic\u00ae delivers new approach to solve challenges for wider cancer populations CHICAGO–(BUSINESS WIRE)–#breastcancer–Brainlab announced today the first group of breast cancer patients treated in United States with the ExacTrac Dynamic\u00ae Deep Inspiration Breath Hold (DIBH) module. Highlands Oncology is the first to treat and has already treated 19 ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-11T15:02:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220808005738\/en\/1538160\/21\/BrainlabDIBHandExacTracDynamic.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Breast Cancer Patients Now Have New Radiation Treatment Option that Visualizes the Heart and Addresses Co-Morbidities\",\"datePublished\":\"2022-08-11T15:02:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\\\/\"},\"wordCount\":683,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220808005738\\\/en\\\/1538160\\\/21\\\/BrainlabDIBHandExacTracDynamic.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\\\/\",\"name\":\"Breast Cancer Patients Now Have New Radiation Treatment Option that Visualizes the Heart and Addresses Co-Morbidities - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220808005738\\\/en\\\/1538160\\\/21\\\/BrainlabDIBHandExacTracDynamic.jpg\",\"datePublished\":\"2022-08-11T15:02:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220808005738\\\/en\\\/1538160\\\/21\\\/BrainlabDIBHandExacTracDynamic.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220808005738\\\/en\\\/1538160\\\/21\\\/BrainlabDIBHandExacTracDynamic.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Breast Cancer Patients Now Have New Radiation Treatment Option that Visualizes the Heart and Addresses Co-Morbidities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Breast Cancer Patients Now Have New Radiation Treatment Option that Visualizes the Heart and Addresses Co-Morbidities - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\/","og_locale":"en_US","og_type":"article","og_title":"Breast Cancer Patients Now Have New Radiation Treatment Option that Visualizes the Heart and Addresses Co-Morbidities - Pharma Trend","og_description":"Brainlab Deep Inspiration Breath Hold with ExacTrac Dynamic\u00ae delivers new approach to solve challenges for wider cancer populations CHICAGO–(BUSINESS WIRE)–#breastcancer–Brainlab announced today the first group of breast cancer patients treated in United States with the ExacTrac Dynamic\u00ae Deep Inspiration Breath Hold (DIBH) module. Highlands Oncology is the first to treat and has already treated 19 ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-11T15:02:15+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220808005738\/en\/1538160\/21\/BrainlabDIBHandExacTracDynamic.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Breast Cancer Patients Now Have New Radiation Treatment Option that Visualizes the Heart and Addresses Co-Morbidities","datePublished":"2022-08-11T15:02:15+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\/"},"wordCount":683,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220808005738\/en\/1538160\/21\/BrainlabDIBHandExacTracDynamic.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\/","url":"https:\/\/pharma-trend.com\/en\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\/","name":"Breast Cancer Patients Now Have New Radiation Treatment Option that Visualizes the Heart and Addresses Co-Morbidities - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220808005738\/en\/1538160\/21\/BrainlabDIBHandExacTracDynamic.jpg","datePublished":"2022-08-11T15:02:15+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220808005738\/en\/1538160\/21\/BrainlabDIBHandExacTracDynamic.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220808005738\/en\/1538160\/21\/BrainlabDIBHandExacTracDynamic.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/breast-cancer-patients-now-have-new-radiation-treatment-option-that-visualizes-the-heart-and-addresses-co-morbidities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Breast Cancer Patients Now Have New Radiation Treatment Option that Visualizes the Heart and Addresses Co-Morbidities"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47202","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47202"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47202\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47202"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47202"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47202"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}